Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Knuckey

Showing results (151-160 of 163) with videos related to

Pageof 17
Sort By:
International Journal of Molecular Sciences|January 28, 2026
Proteome-Wide Serological Profiling Reveals Broad Elevation of EBV Immunity in Idiopathic Pulmonary FibrosisYomani D Sarathkumara, Kiara M Knuckey, Viviana P Lutzky, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|February 12, 2015
Poly-arginine and arginine-rich peptides are neuroprotective in stroke modelsBruno P Meloni, Laura M Brookes, Vince W Clark, et al.
Neurosurgery|July 1, 1995
A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasmJ M Findlay, N F Kassell, B K Weir, et al.
Communicable Diseases Intelligence Quarterly Report|October 21, 2011
Australia's notifiable disease status, 2009: annual report of the National Notifiable Diseases Surveillance SystemTimothy Slaon-Gardner, Stefan Stirzaker, Dougald Knuckey, et al.
Communicable Diseases Intelligence Quarterly Report|November 3, 2009
Australia's notifiable disease status, 2007: annual report of the National Notifiable Diseases Surveillance SystemConan Liu, Stefan Stirzaker, Dougald Knuckey, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|December 14, 2019
Poly-Arginine Peptide-18 (R18) Reduces Brain Injury and Improves Functional Outcomes in a Nonhuman Primate Stroke ModelBruno P Meloni, Yining Chen, Kathleen A Harrison, et al.
Communicable Diseases Intelligence Quarterly Report|November 17, 2012
Australia's notifiable disease status, 2010: annual report of the National Notifiable Diseases Surveillance System, Alison Milton, Stefan Stirzaker, et al.
Neuroscience and Biobehavioral Reviews|February 23, 2016
Cerebral amyloid-β accumulation and deposition following traumatic brain injury--A narrative review and meta-analysis of animal studiesSabine M Bird, Hamid R Sohrabi, Thomas A Sutton, et al.
Research Involvement and Engagement|January 29, 2026
Establishing a set of acceptable demographic questions for use in health research through public consultationEmma Lidington, Morgaine Stiles, Jessica Maudsley, et al.
Communicable Diseases Intelligence Quarterly Report|November 25, 2010
Australia's notifiable disease status, 2008: annual report of the National Notifiable Diseases Surveillance System, Leah Newman, Stefan Stirzaker, et al.
Pageof 17

Showing results (151-160 of 163) with videos related to

Sort By:
Pageof 17
International Journal of Molecular Sciences|January 28, 2026
Proteome-Wide Serological Profiling Reveals Broad Elevation of EBV Immunity in Idiopathic Pulmonary FibrosisYomani D Sarathkumara, Kiara M Knuckey, Viviana P Lutzky, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|February 12, 2015
Poly-arginine and arginine-rich peptides are neuroprotective in stroke modelsBruno P Meloni, Laura M Brookes, Vince W Clark, et al.
Neurosurgery|July 1, 1995
A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasmJ M Findlay, N F Kassell, B K Weir, et al.
Communicable Diseases Intelligence Quarterly Report|October 21, 2011
Australia's notifiable disease status, 2009: annual report of the National Notifiable Diseases Surveillance SystemTimothy Slaon-Gardner, Stefan Stirzaker, Dougald Knuckey, et al.
Communicable Diseases Intelligence Quarterly Report|November 3, 2009
Australia's notifiable disease status, 2007: annual report of the National Notifiable Diseases Surveillance SystemConan Liu, Stefan Stirzaker, Dougald Knuckey, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|December 14, 2019
Poly-Arginine Peptide-18 (R18) Reduces Brain Injury and Improves Functional Outcomes in a Nonhuman Primate Stroke ModelBruno P Meloni, Yining Chen, Kathleen A Harrison, et al.
Communicable Diseases Intelligence Quarterly Report|November 17, 2012
Australia's notifiable disease status, 2010: annual report of the National Notifiable Diseases Surveillance System, Alison Milton, Stefan Stirzaker, et al.
Neuroscience and Biobehavioral Reviews|February 23, 2016
Cerebral amyloid-β accumulation and deposition following traumatic brain injury--A narrative review and meta-analysis of animal studiesSabine M Bird, Hamid R Sohrabi, Thomas A Sutton, et al.
Research Involvement and Engagement|January 29, 2026
Establishing a set of acceptable demographic questions for use in health research through public consultationEmma Lidington, Morgaine Stiles, Jessica Maudsley, et al.
Communicable Diseases Intelligence Quarterly Report|November 25, 2010
Australia's notifiable disease status, 2008: annual report of the National Notifiable Diseases Surveillance System, Leah Newman, Stefan Stirzaker, et al.
Pageof 17